Overview: When validated methods are transferred between laboratories and sites, their validated state should be maintained to ensure the same reliable results in the receiving laboratory.
So far there have not been official guidance on what exactly is expected to maintain 'the validated state'. Now the USP is preparing for a general chapter and the FDA has released an official guidance on how to conduct and document method transfer. The guide has been developed for medicated feed assays but the principles can be applied to other methods. Now it is a good time to learn how to conduct and document method transfer for FDA compliance.
Areas Covered in the Session:
FDA and International regulations for method transfer
Examples of FDA warning letters and how to avoid them
The FDA Guidance on method transfer.
The proposal for a new USP chapter
Developing a strategy for analytical method transfer
Developing an SOP for method transfer
Responsibilities of the transferring and receiving laboratory
Developing a transfer plan: contents and approval
The importance of acceptance criteria
Conducting comparative studies
Dealing with technology transfer: validation requirements, regulatory notification.
Method transfer from standard HPLC to (ultra)fast HPLC
Most likely failures during method transfer
Handling deviations from documented acceptance criteria
Criteria for transfer waiver (omission of formal transfer)